NewAmsterdam Pharma Co N.V Ratios (2022-2025) | NAMS

Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -486.94%-2,230.11%-1,602.62%-6,160.40%-6,692.86%-1,711.58%-57.19%-721.71%-1,327.30%-90.70%-20,691.09%
EBIT Margin -461.85%-2,474.20%-1,685.07%-6,360.40%-3,960.17%-2,306.93%-85.89%-338.47%-2,314.47%-186.13%-15,845.69%
EBITDA Margin -486.94%-2,230.11%-1,602.62%-6,163.76%-6,692.86%-1,711.58%-57.18%-721.36%-1,328.41%-91.26%-20,601.15%
Operating Margin -461.85%-2,474.20%-1,685.07%-6,360.40%-3,960.17%-2,306.93%-85.89%-338.47%-2,314.47%-186.13%-15,845.69%
Net Margin -486.94%-2,230.11%-1,602.62%-6,160.40%-6,692.86%-1,711.58%-57.18%-721.71%-1,327.30%-90.70%-20,691.09%
FCF Margin -369.34%-1,707.05%-1,597.59%-4,119.18%-3,924.84%-2,377.71%-43.20%-293.49%-1,225.12%-197.23%-9,428.45%
Efficiency
Assets Average 417.78M467.58M442.94M651.91M841.52M816.76M800.77M
Equity Average 414.24M385.88M352.59M310.11M350.10M399.62M383.15M568.18M767.43M777.93M753.28M
Invested Capital 434.21M398.41M381.76M331.83M300.97M444.86M410.98M397.76M795.01M800.89M799.43M772.43M
Asset Utilization Ratio 0.020.020.080.070.060.080.04
Leverage & Solvency
Debt to Equity 0.010.020.040.080.060.050.050.030.030.06
Debt Ratio 0.010.040.070.050.040.040.030.030.06
Equity Ratio 0.790.830.840.870.860.880.950.960.93
Valuation
Enterprise Value 378.96M640.17M553.04M532.16M746.92M1,630.01M1,297.74M1,071.53M1,540.13M1,439.49M1,294.06M2,500.21M
Market Capitalization 846.69M1,081.48M969.75M900.46M1,087.37M2,111.16M1,728.45M1,494.25M2,374.32M2,247.97M2,033.22M3,203.15M
Return Ratios
Return on Sales -12.56%-33.32%-30.90%-5.92%-5.30%-3.97%-2.59%-6.27%
Return on Capital Employed -0.55%-0.49%-0.46%-0.32%-0.24%-0.22%-0.27%
Return on Assets -0.55%-0.49%-0.45%-0.37%-0.22%-0.20%-0.28%
Return on Equity -0.57%-0.65%-0.57%-0.52%-0.43%-0.24%-0.21%-0.29%